273 related articles for article (PubMed ID: 2948385)
1. Characterization of a distinct subgroup of high-risk persons with Kaposi's sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic test results.
Afrasiabi R; Mitsuyasu RT; Nishanian P; Schwartz K; Fahey JL
Am J Med; 1986 Dec; 81(6):969-73. PubMed ID: 2948385
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma and HTLV-III: a study in Nigerian adult males.
Otu AA
J R Soc Med; 1986 Sep; 79(9):510-4. PubMed ID: 3021963
[TBL] [Abstract][Full Text] [Related]
3. Lymphadenopathic type of Kaposi's sarcoma in a Ugandan child seropositive for LAV/HTLV-III antibodies.
Marquart KH; Müller HA; Hartter P; Oku JC; Ayuko WO
J Trop Med Hyg; 1987 Apr; 90(2):93-4. PubMed ID: 3470530
[TBL] [Abstract][Full Text] [Related]
4. Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma.
Taylor J; Afrasiabi R; Fahey JL; Korns E; Weaver M; Mitsuysau R
Blood; 1986 Mar; 67(3):666-71. PubMed ID: 3081065
[TBL] [Abstract][Full Text] [Related]
5. T4/T8 ratio and absolute T4 cell numbers in different clinical stages of Kaposi's sarcoma in AIDS.
Spornraft P; Fröschl M; Ring J; Meurer M; Goebel FD; Ziegler-Heitbrock HW; Riethmüller G; Braun-Falco O
Br J Dermatol; 1988 Jul; 119(1):1-9. PubMed ID: 3261596
[TBL] [Abstract][Full Text] [Related]
6. Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma.
Schroff RW; Gottlieb MS; Prince HE; Chai LL; Fahey JL
Clin Immunol Immunopathol; 1983 Jun; 27(3):300-14. PubMed ID: 6603314
[TBL] [Abstract][Full Text] [Related]
7. Antibody to the AIDS virus in Kaposi's sarcoma in Nigeria.
Otu AA
J Surg Oncol; 1988 Mar; 37(3):152-5. PubMed ID: 3162540
[TBL] [Abstract][Full Text] [Related]
8. Immunological characterizations of patients with acquired immune deficiency syndrome, acquired immune deficiency syndrome-related symptom complex, and a related life-style.
Hersh EM; Mansell PW; Reuben JM; Rios A; Newell GR
Cancer Res; 1984 Dec; 44(12 Pt 1):5894-901. PubMed ID: 6209006
[TBL] [Abstract][Full Text] [Related]
9. Immunologic abnormalities in homosexual men. Relationship to Kaposi's sarcoma.
Stahl RE; Friedman-Kien A; Dubin R; Marmor M; Zolla-Pazner S
Am J Med; 1982 Aug; 73(2):171-8. PubMed ID: 7114072
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of Kaposi's sarcoma in the epidemic of AIDS.
Safai B; Sarngadharan MG; Koziner B; Godbold J; Myskowski PL; Cunningham-Rundles S; Johnson K; Gold J; Krown S; Dupont B
Cancer Res; 1985 Sep; 45(9 Suppl):4646s-4648s. PubMed ID: 2990700
[TBL] [Abstract][Full Text] [Related]
11. HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa.
Bayley AC; Downing RG; Cheingsong-Popov R; Tedder RS; Dalgleish AG; Weiss RA
Lancet; 1985 Feb; 1(8425):359-61. PubMed ID: 2857417
[TBL] [Abstract][Full Text] [Related]
12. Disseminated Kaposi's sarcoma not associated with HIV infection in a bisexual man.
García-Muret MP; Pujol RM; Puig L; Moreno A; de Moragas JM
J Am Acad Dermatol; 1990 Nov; 23(5 Pt 2):1035-8. PubMed ID: 2229537
[TBL] [Abstract][Full Text] [Related]
13. The Walter Reed staging classification for HTLV-III/LAV infection.
Redfield RR; Wright DC; Tramont EC
N Engl J Med; 1986 Jan; 314(2):131-2. PubMed ID: 2934633
[TBL] [Abstract][Full Text] [Related]
14. Analysis of T cell subsets in different clinical subgroups of patients with the acquired immune deficiency syndrome. Comparison with the "classic" form of Kaposi's sarcoma.
Mittelman A; Wong G; Safai B; Myskowski P; Gold J; Koziner B
Am J Med; 1985 Jun; 78(6 Pt 1):951-6. PubMed ID: 2990205
[TBL] [Abstract][Full Text] [Related]
15. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
[TBL] [Abstract][Full Text] [Related]
16. Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary results.
Longo DL; Steis RG; Lane HC; Lotze MT; Rosenberg SA; Preble O; Masur H; Rook AH; Fauci AS; Jacob J
Ann N Y Acad Sci; 1984; 437():421-30. PubMed ID: 6598311
[TBL] [Abstract][Full Text] [Related]
17. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
Bihl F; Berger C; Chisholm JV; Henry LM; Bertisch B; Trojan A; Nadal D; Speck RF; Flepp M; Brander C; Mueller NJ;
AIDS; 2009 Sep; 23(14):1918-22. PubMed ID: 19609199
[TBL] [Abstract][Full Text] [Related]
18. Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders.
Fahey JL; Prince H; Weaver M; Groopman J; Visscher B; Schwartz K; Detels R
Am J Med; 1984 Jan; 76(1):95-100. PubMed ID: 6229182
[TBL] [Abstract][Full Text] [Related]
19. Relationship of exposure to human T lymphotropic virus and T helper cells in homosexual men.
Reuben JM; LaRocco JM; Gschwind CR; Stroud C; Rios A; Hersh EM; Mansell PW
AIDS Res; 1986; 2(2):117-26. PubMed ID: 3013220
[TBL] [Abstract][Full Text] [Related]
20. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
